Healthcare company Abbott has announced that its smartphone compatible Confirm Insertable Cardiac Monitor (ICM) has gained CE Mark approval. more

May 9, 2017 11:45 AM Devices

The Food and Drug Administration (FDA) has warned medical device maker Abbott that it must submit a plan to address any cybersecurity issues and other safety issues identified in cardiac devices from the company’s recently acquired St Jude Medical. more

Apr 21, 2017 10:00 AM News

Abbott is aiming to recruit more than 150 people to work at its UK diabetes care manufacturing hub in Witney, Oxfordshire more

May 6, 2016 3:58 PM News

The US Food and Drug Administration (FDA) Advisory Committee gives Abbott’s fully dissolving heart stent a positive review and recommends the FDA approve it more

Mar 17, 2016 10:46 AM News

A drug-eluting coronary stent made of a biodegradable polymer performed similarly to the gold-standard metal one in a non-inferiority trial among patients with the more serious type of heart attack known as ST-segment elevation myocardial infarction more

Nov 19, 2015 5:00 PM News

Abbott has announced positive one-year clinical results from the Absorb III trial more

Oct 19, 2015 2:49 PM News

Diabetes Professional Care 2015 will take place at the Barbican Exhibition Centre in London from 11-12 November more

Oct 7, 2015 10:05 AM News

Done deal: Abbott has completed its acquisition of Topera, a medical device company focused on developing innovative electrophysiology technologies more

Dec 23, 2014 10:39 AM News

In the lead: The growing market for glucose monitoring devices in Benelux and Scandinavian countries is currently led by Roche more

Jul 6, 2014 5:33 PM News

Enlight from St Jude Medical.

Source: St Jude Medical.

Technologies for minimally invasive devices are a fast developing area. As tubes get smaller, thinner and stronger, surgeons are expected to be able to access areas of the body with more accuracy and less pain for the patient. more

Jul 22, 2013 8:00 AM Devices

BASF's announcement of a €10 bn investment over seven years in Asia will stimulate much activity in the region, especially in plastics. Clinical trials of Abbott's Absorb stent in Japan are influential too. more

Jul 2, 2013 12:00 AM News

Abbott (NYSE: ABT) today announced CE Marking (Conformité Européenne) for the ARCHITECT clinical chemistry Hemoglobin A1c (HbA1c) test, which may aid physicians in diagnosing and monitoring diabetes as well as identifying patients at risk for develop more

May 9, 2013 12:00 AM News

US headquartered healthcare product manufacturer Abbott has published data which the company says supports the long-term performance of its Absorb bioresorbable vascular stent. more

Mar 15, 2013 12:00 AM Devices

US-headquartered device manufacturer Abbott announced today the initiation of the Absorb III clinical trial in patients in the United States. more

Jan 8, 2013 12:00 AM Devices

Built with Metro Publisher™